Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/PHARNEXT-SCA-29750723/actualite/PHARNEXT-inclusion-du-premier-patient-dans-l-essai-de-phase-3-dans-la-maladie-CMT1A-32845943/?utm_source=whatsapp&utm_medium=social&utm_campaign=share